Item type:Thesis, Open Access

Vergleich Gastrinrezeptorszintigraphie mit 111-In-DTPA-D-Glu1-Minigastrin versus Somatostatinrezeptorszintigraphie mit 111-In-DTPA-D-Phe1-Octreotid bei Patienten mit neuroendokrinen Tumoren.

Thumbnail Image

Files

djg.pdf (3.69 MB)

Date

2006-07-20

Authors

Publisher

Philipps-Universität Marburg
DOI

Supervisors

Abstract

60 patients with neuroendocrine tumors received a somatostatin receptor szintigraphy (SRS) and a gastrin receptor scintigraphy (GRS) (51 carcinoids, 3 gastrinomas, 2 glucagonomas, 1 insulinoma, 3 paragangliomas). In 81.7% of the patients, SRS detected tumor lesions. In GRS, 78.3% were positive. In 68.3%, both techniques showed positive results. GRS was positive in 54.5% of SRS negative patients. Overall, GRS showed a better performance than SRS in 21.7% while SRS was better in 40.0%. Conclusion: Though overall performance of SRS may be better, GRS should be performed in patients with gastrointestinal neuroendocrine tumors after SRS, when SRS is negative.

Review

Metadata

Contributors
Supervisor:
Dates
Created: 2006Issued: 2006-07-20Updated: 2011-08-10
DOI
https://doi.org/10.17192/z2006.0495
Faculty
Medizin
Publisher
Philipps-Universität Marburg
Language
ger
Data types
DoctoralThesis
Keywords
GastrinGastrinSomatostatinNeuroendokrine TumorenNeuroendocrine tumorsSomatostatin
DFG-subjects
Szintigraphie
DDC-Numbers
610
License
https://rightsstatements.org/vocab/InC-NC/1.0/
URI
https://open.uni-marburg.de/handle/10.17192/z2006.0495
show more
Graß, Julia: Vergleich Gastrinrezeptorszintigraphie mit 111-In-DTPA-D-Glu1-Minigastrin versus Somatostatinrezeptorszintigraphie mit 111-In-DTPA-D-Phe1-Octreotid bei Patienten mit neuroendokrinen Tumoren.. : Philipps-Universität Marburg 2006-07-20. DOI: https://doi.org/10.17192/z2006.0495.

License

item.page.license.under-copyright
This item has been published with the following license: In Copyright